Levetiracetam Clinical Trials

• Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures.
  ClinicalTrials.gov Identifier: NCT00152516 - Recruiting
  Epilepsy, Partial
  
• The Effects of Levetiracetam on Alcohol Dependent Subjects
  ClinicalTrials.gov Identifier: NCT00325182 - Active, not recruiting
  Alcoholism
  
• Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
  ClinicalTrials.gov Identifier: NCT00141115 - Active, not recruiting
  Alcoholism; Generalized Anxiety Disorder; Panic Disorder; Social Phobia; Substance-induced anxiety disorder
  
• A Study to Determine If Levetiracetam Will Assist Those Suffering from Chronic Idiopathic Axonal Polyneuropathy.
  ClinicalTrials.gov Identifier: NCT00156689 - Recruiting
  Chronic Idiopathic Axonal Polyneuropathy
  
• Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175
  ClinicalTrials.gov Identifier: NCT00291655 - Active, not recruiting
  Epilepsy
  
• A Double-Blind Confirmatory Trial of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
  ClinicalTrials.gov Identifier: NCT00280696 - Active, not recruiting
  Epilepsies, Partial
  
• Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
  ClinicalTrials.gov Identifier: NCT00160615 - Active, not recruiting
  Epilepsy, Partial
  
• Levetiracetam for Benign Rolandic Epilepsy
  ClinicalTrials.gov Identifier: NCT00181116 - Active, not recruiting
  Epilepsy
  
• Seizure Therapy With Intravenous Levetiracetam and Lorazepam
  ClinicalTrials.gov Identifier: NCT00465244 - Recruiting
  Seizures
  
• Levetiracetam for Neuroprotection Against Corticosteroid-Induced Hippocampal Dysfunction: A Proof of Concept Study
  ClinicalTrials.gov Identifier: NCT00223223 - Active, not recruiting
  Memory Loss Associated With Corticosteroid Use; Manic State Associated With Corticosteroid Use
  
• Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases
  ClinicalTrials.gov Identifier: NCT00415376 - Active, not recruiting
  Brain and Central Nervous System Tumors; Seizure; Unspecified Adult Solid Tumor, Protocol Specific
  
• Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
  ClinicalTrials.gov Identifier: NCT00245713 - Active, not recruiting
  Epilepsy, Partial
  
• Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00291733 - Active, not recruiting
  Levodopa Induced Dyskinesia
  
• Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
  ClinicalTrials.gov Identifier: NCT00319605 - Recruiting
  Epilepsy
  
• Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00160628 - Completed
  Epilepsy, Partial
  
• Pregabalin Versus Levetiracetam in Partial Seizures.
  ClinicalTrials.gov Identifier: NCT00537238 - Recruiting
  Epilepsy; Epilepsies, Partial
  
• Open Label Safety Efficacy Study of Levetiracetam in Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00152373 - Completed
  Epilepsy, Partial
  
• Open Label Safety and Efficacy Study of Levetiracetam in Patients with Epilepsy
  ClinicalTrials.gov Identifier: NCT00160654 - Completed
  Epilepsy, Partial
  
• Study of Hormonal Sideeffects in Patients Taking Levetiracetam, Carbamazepine or Lamotrigine for Epilepsy
  ClinicalTrials.gov Identifier: NCT00460070 - Recruiting
  Epilepsy
  
• Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
  ClinicalTrials.gov Identifier: NCT00535392 - Recruiting
  Epilepsy
  
• Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis
  ClinicalTrials.gov Identifier: NCT00542802 - Recruiting
  Epileptic Seizures; Stroke
  
• Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients
  ClinicalTrials.gov Identifier: NCT00577005 - Recruiting
  Cocaine Dependence; Opioid Dependency
  
• Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy
  ClinicalTrials.gov Identifier: NCT00242606 - Recruiting
  Epilepsy
  
• Monotherapy with Levetiracetam in Newly Diagnosed Patients Suffering from Epilepsy.
  ClinicalTrials.gov Identifier: NCT00150735 - Completed
  Generalized Epilepsy
  
• IV Levetiracetam for the Treatment of Neonatal Seizures: a Pharmacokinetic and Preliminary Efficacy and Safety Study
  ClinicalTrials.gov Identifier: NCT00461409 - Recruiting
  Seizures; Term Neonates
  
• An Open Long Term Follow up Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
  ClinicalTrials.gov Identifier: NCT00367432 - Recruiting
  Epilepsies, Partial
  
• Levetiracetam as Add-on Treatment of Myoclonic Jerks in Adolescents + Adults
  ClinicalTrials.gov Identifier: NCT00150774 - Completed
  Generalized Convulsive Epilepsy
  
• Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome
  ClinicalTrials.gov Identifier: NCT00146471 - Not yet recruiting
  alcohol dependence according to DSM-IV/ICD-10; Withdrawal Symptoms; inpatient
  
• Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease
  ClinicalTrials.gov Identifier: NCT00324454 - Active, not recruiting
  Motor Neuron Disease; Amyotrophic Lateral Sclerosis; Primary Lateral Sclerosis; Progressive Muscular Atrophy
  
• Long Term Follow Up Treatment with Levetiracetam in Subjects of 4 Years and Older with Generalized Epilepsy
  ClinicalTrials.gov Identifier: NCT00150748 - Completed
  Generalized Epilepsy
  
• Levetiracetam for Treatment of Pain Associated With Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00254657 - Recruiting
  Fibromyalgia
  
• Open-Label (Everyone Who Participates Receives Drug), Long-Term, Follow-Up Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
  ClinicalTrials.gov Identifier: NCT00150709 - Completed
  Epilepsy, Partial
  
• Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-Induced Dyskinesias in Advanced Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00307450 - Recruiting
  Parkinson's Disease
  
• Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery
  ClinicalTrials.gov Identifier: NCT00571155 - Recruiting
  Primary Brain Tumor; Epilepsy
  
• Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
  ClinicalTrials.gov Identifier: NCT00454935 - Recruiting
  Epilepsy; Glioma
  
• Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
  ClinicalTrials.gov Identifier: NCT00362141 - Recruiting
  Status Epilepticus
  
• Monotherapy with Levetiracetam or Carbamazepine in Patients Suffering from Epilepsy.
  ClinicalTrials.gov Identifier: NCT00150787 - Completed
  Epilepsy, Tonic-Clonic
  
• Prevention of Post-Traumatic Seizures With Levetiracetam
  ClinicalTrials.gov Identifier: NCT00566046 - Recruiting
  Epilepsy, Post-Traumatic
  
• Monotherapy with Levetiracetam in Patients Suffering from Epilepsy.
  ClinicalTrials.gov Identifier: NCT00150813 - Completed
  Epilepsy, Tonic-Clonic
  
• Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00252954 - Recruiting
  Injuries, Spinal Cord; Pain
  
• A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy
  ClinicalTrials.gov Identifier: NCT00361010 - Recruiting
  Epilepsy; Childhood Absence Epilepsy; Seizures
  
• Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
  ClinicalTrials.gov Identifier: NCT00505934 - Not yet recruiting
  Epilepsy
  
• Levetiracetam in the Management of Bipolar Depression
  ClinicalTrials.gov Identifier: NCT00566150 - Recruiting
  Bipolar Depression
  
• Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder
  ClinicalTrials.gov Identifier: NCT00265109 - Recruiting
  Body Dysmorphic Disorder
  
• Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00299611 - Recruiting
  Obsessive-Compulsive Disorder
  
• Levetiracetam for Painful Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00286260 - Recruiting
  Painful Polyneuropathy
  
• The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00430599 - Not yet recruiting
  Multiple Sclerosis
  
• Levetiracetam in Central Pain in MS
  ClinicalTrials.gov Identifier: NCT00423527 - Not yet recruiting
  Central Pain in Multiple Sclerosis
  
• Levetiracetam in Post-Traumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00413296 - Recruiting
  Post-Traumatic Stress Disorder
  
• Levetiracetam Treatment of Children With Subclinical Sleep-Activated Epileptiform Activity (SSEA) – a Placebo Controlled Double-Blind Cross-Over-Study
  ClinicalTrials.gov Identifier: NCT00393614 - Not yet recruiting
  Subclinical Sleep-Activated Epileptiform Activity; CSWS
  
• Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old
  ClinicalTrials.gov Identifier: NCT00544050 - Completed
  Epilepsy
  
• The Effect of Levetiracetam on the Postmastectomy Pain Syndrome
  ClinicalTrials.gov Identifier: NCT00262262 - Completed
  Postoperative Pain
  
• A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)
  ClinicalTrials.gov Identifier: NCT00160511 - Completed
  Neuralgia, Postherpetic
  
• Levetiracetam Treatment in Adult Subjects With Parkinson’s Disease Experiencing Troublesome Dyskinesias
  ClinicalTrials.gov Identifier: NCT00160576 - Completed
  Idiopathic Parkinson Disease
  
• A Placebo-Controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.
  ClinicalTrials.gov Identifier: NCT00175890 - Completed
  Epilepsy, Partial
  
• Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy.
  ClinicalTrials.gov Identifier: NCT00175903 - Completed
  Epilepsy
  
• Cognitive Function in Pediatric Epilepsy
  ClinicalTrials.gov Identifier: NCT00105040 - Completed
  Epilepsy
  
• A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures
  ClinicalTrials.gov Identifier: NCT00545012 - Completed
  Absence Seizures
  
• Levetiracetam in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
  ClinicalTrials.gov Identifier: NCT00175955 - Completed
  Dyskinesia, Medication-Induced
  
• Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness
  ClinicalTrials.gov Identifier: NCT00015769 - Completed
  Bipolar Disorder
  
• Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-Clonic Seizures
  ClinicalTrials.gov Identifier: NCT00160550 - Completed
  Generalized Convulsive Epilepsy
  
• A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
  ClinicalTrials.gov Identifier: NCT00247364 - Completed
  Restless Legs Syndrome
  
• Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks
  ClinicalTrials.gov Identifier: NCT00279617 - Completed
  Panic Disorder
  
• Levetiracetam Treatment of L-dopa Induced Dyskinesias
  ClinicalTrials.gov Identifier: NCT00076674 - Completed
  Dyskinesias; Parkinson Disease
  
• Effect of Levetiracetam on Brain Excitability
  ClinicalTrials.gov Identifier: NCT00006191 - Completed
  Healthy; Myoclonic Epilepsy
  
• Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
  ClinicalTrials.gov Identifier: NCT00518570 - Completed
  Premenstrual Dysphoric Disorder
  
• Levetiracetam Treatment of Tardive Dyskinesia
  ClinicalTrials.gov Identifier: NCT00291213 - Completed
  Tardive Dyskinesia